Successful Treatment with Olanzapine of Psychosis in Dentatorubral-pallidoluysian Atrophy: A Case Report
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Patients with dentatorubral-pallidoluysian atrophy occasionally elicit psychosis. So far, one study reported first generation antipsychotics drugs may provide an effective treatment; however, there is no literature on the benefits of second generation antipsychotics. We report on a 44-year-old man with dentatorubral-pallidoluysian atrophy whose psychotic symptoms were effectively treated with olanzapine. Our observation suggests some second generation antipsychotics provide a therapeutic option for ameliorating psychosis in dentatorubral-pallidoluysian atrophy.
Abstract
Patients with dentatorubral-pallidoluysian atrophy occasionally elicit psychosis. So far, one study reported first generation antipsychotics drugs may provide an effective treatment; however, there is no literature on the benefits of second generation antipsychotics. We report on a 44-year-old man with dentatorubral-pallidoluysian atrophy whose psychotic symptoms were effectively treated with olanzapine. Our observation suggests some second generation antipsychotics provide a therapeutic option for ameliorating psychosis in dentatorubral-pallidoluysian atrophy.
참고문헌 (15)
- Ikeuchi T, "Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat", Ann Neurol, 37, pp.769~775 (1995)[DOI]
- Koide R, "Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA)", Nat Genet, 6, pp.9~13 (1994)[DOI]
- Inatsuki G, "Geographical distribution of origins of DRPLA family in Japan, and prevalence of DRPLA in Niigata prefecture", Seishin Igaku, 32, pp.1135~1138 (1990)
- Burke JR, "Dentatorubral-pallidoluysian atrophy and Haw Rever syndrome", Lancet, 344, pp.1711~1712 (1994)[DOI]
- Warner TT, "A clinical and molecular genetic study of dentatorubropallidoluysian atrophy in four European families", Ann Neurol, 37, pp.452~459 (1995)[DOI]
- Naito H, "Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy", Neurology, 32, pp.789~807 (1982)[DOI]
- Takahashi H, "Hereditary dentatorubral-pallidoluysian atrophy: clinical and pathological variants in a family", Neurology, 38, pp.1065~1070 (1988)[DOI]
- Adachi N, "Dentatorubral-pallidoluysian atrophy (DRPLA) presenting with psychosis", J Neuropsychiatry Clin Neurosci, 13, pp.258~260 (2001)[DOI]
- Naito H, "A family of dentatorubropallidoluysian atrophy (DRPLA) including two cases with schizophrenic symptoms", Psychiatr Neurol Jpn, 74, pp.871~897 (1987)
- Adachi N, "Four cases of progressive myoclonus epilepsy with paranoid state", Seishin Igaku, 34, pp.745~750 (1992)
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders", American Psychiatric Association, 114~115 (2013)
- Shoji Y, "Clinical application of second generation antipsychotics to organic, including symptomatic, mental disorders-possibility of second generation antipsychotics to adaptiatino expansion for delirium and", or higher brain disorder, 2009, pp.12, 679~688
- Halstead SM, "Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia", Br J Psychiatry, 164, pp.177~183 (1994)[DOI]
- Glazer WM, "Expected incidence of tardive dyskinesia associated with atypical antipsychotics", J Clin Psychiatry, 61(Suppl 4), pp.21~26 (2000)
- Carlson CD, "An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine", J Clin Psychiatry, 64, pp.898~906 (2003)[DOI]
